Skip to main content

Aquarius Population Health

Menu
Menu

Aquarius Population Health

Find out more about us

"Every problem will be an adventure."

Discover our values

Want to join our growing team and make a difference?

View our current positions

"Think differently, together."

Discover our values

We generate the evidence required to inform rational healthcare decisions

Learn more about our work

"Data has no spirit without logic and story."

Discover our values

Services

The Aquarius team is ready to take on our clients’ challenges to support their success

Economic
Evaluation

Compelling economic evidence is essential when bringing a product to market.

Evidence
& Insight

How do payers and patients think? What are the market opportunities and challenges for products?

Interactive
Decision Tools

Imagine an easy to use application with a powerful analytical engine that communicates your messages brilliantly.

Pathway Mapping
& Costing

Understanding how to transform current patient journeys is crucial for assessing new opportunities in healthcare innovation.

Writing & Communication

We have a broad range of in-house skills to communicate with diverse audiences for different purposes.

Economic Evaluation

Compelling economic evidence is essential when bringing a product to market.

Evidence Insight

How do payers and patients think? What are the market opportunities and challenges for products?

Interactive Decision Tools

Imagine an easy to use application with a powerful analytical engine that communicates your messages brilliantly.

Pathway Mapping & Costing

Understanding how to transform current patient journeys is crucial for assessing new opportunities in healthcare innovation.

Writing & Communication

We have a broad range of in-house skills to communicate with diverse audiences for different purposes.

Latest News

Economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing

Economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing

Read more >
Looking at the cost implications of using PCR-based respiratory panel assays for patients admitted to hospital with pneumonia in the UK, France and Spain

Looking at the cost implications of using PCR-based respiratory panel assays for patients admitted to hospital with pneumonia in the UK, France and Spain

Read more >
Economic evaluation of different sampling strategies for cervical cancer screening

Economic evaluation of different sampling strategies for cervical cancer screening

Read more >
Tales from opposite corners of the world: Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany

Tales from opposite corners of the world: Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany

Australia and Germany have both made progress toward HIV and viral hepatitis elimination targets, yet a significant share of infections remains undiagnosed. HBV: 31% undiagnosed in Australia (3); 80% in Germany (4) HCV: 16% undiagnosed in Australia (5); 63% in Germany (6) HIV: around 8% undiagnosed in both countries (7,8)…

For an intro chat about your needs or to receive Aquarius updates

Contact us